Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
SEC Accession No. 0000921895-25-000985
Filing Date
2025-04-04
Accepted
2025-04-04 16:23:08
Documents
6

Document Format Files

Seq Description Document Type Size
1 prrn14a14390002_04042025.htm PRRN14A 347442
2 GRAPHIC image_003.jpg GRAPHIC 8902
3 GRAPHIC image_004.jpg GRAPHIC 32991
4 GRAPHIC image_005.jpg GRAPHIC 33018
5 GRAPHIC image_006.jpg GRAPHIC 35724
6 GRAPHIC image_008.jpg GRAPHIC 33018
  Complete submission text file 0000921895-25-000985.txt   547611
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27709
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27709 248-681-9815
Opus Genetics, Inc. (Subject) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRRN14A | Act: 34 | File No.: 001-34079 | Film No.: 25815070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address
Sooch Mina (Filed by) CIK: 0001674006 (see all company filings)

Type: PRRN14A